Intrinsic Value of S&P & Nasdaq Contact Us

DocGo Inc. DCGO NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
55/100
2/7 Pass
SharesGrow Intrinsic Value
$356,478,000.00
+66186037776%
Analyst Price Target
$1.50
+178.5%

DocGo Inc. (DCGO) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 7 Buy, 1 Hold.

The consensus price target is $1.50, representing an upside of 178.5% from the current price $0.54.

Analysts estimate Earnings Per Share (EPS) of $0.25 and revenue of $0.63B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $0.20 vs est $0.25 (missed -21.1%). 2025: actual $-1.84 vs est $-0.67 (missed -174.6%). Analyst accuracy: 55%.

DCGO Stock — 12-Month Price Forecast

$1.50
▲ +178.50% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for DocGo Inc., the price target is $1.50.
The average price target represents a +178.50% change from the last price of $0.54.

DCGO Analyst Ratings

Buy
8
Ratings
7 Buy
1 Hold
Based on 8 analysts giving stock ratings to DocGo Inc. in the past 3 months
Rating breakdown
Buy
7 88%
Hold
1 13%
88%
Buy
7 analysts
13%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — DCGO

55%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.20 vs Est $0.25 ▼ 26.7% off
2025 Actual –$1.84 vs Est –$0.67 ▼ 63.6% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.

Revenue Estimates — DCGO

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.617B vs Est $0.625B ▼ 1.4% off
2025 Actual $0.322B vs Est $0.318B ▲ 1.4% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message